title: Severe catheter related bacteremia due to Pseudomonas luteola.
authors.forename: M-P
authors.initials: MP
authors.lastname: Otto
authors.forename: B
authors.initials: B
authors.lastname: Foucher
authors.forename: E
authors.initials: E
authors.lastname: Dardare
authors.forename: P
authors.initials: P
authors.lastname: Gérôme
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D016470:Bacteremia / Q000382:microbiology*; D001803:Blood Transfusion; D002277:Carcinoma / Q000150:complications / Q000188:drug therapy; D055499:Catheter-Related Infections / Q000382:microbiology*; D002405:Catheterization, Central Venous / Q000009:adverse effects; D062905:Central Venous Catheters / Q000382:microbiology; D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects; D003428:Cross Infection / Q000382:microbiology*; D024901:Drug Resistance, Multiple, Bacterial; D004866:Equipment Contamination; D006801:Humans; D016867:Immunocompromised Host; D007362:Intensive Care Units; D008175:Lung Neoplasms / Q000150:complications / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009894:Opportunistic Infections / Q000382:microbiology*; D011549:Pseudomonas / Q000145:classification / Q000187:drug effects / Q000302:isolation & purification* / Q000472:pathogenicity; D011552:Pseudomonas Infections / Q000382:microbiology*; D018805:Sepsis / Q000382:microbiology; D014747:Vinblastine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives; D000077235:Vinorelbine; D014774:Virulence
chemical_list: D014747:Vinblastine; D002945:Cisplatin; D000077235:Vinorelbine